Results 151 to 160 of about 80,641 (196)

Cyclosporin A

Journal of the American Academy of Dermatology, 1986
Cyclosporin A is a new immunosuppressive agent that selectively affects T helper cells without suppressing the bone marrow. Cyclosporin A has been used primarily to prevent rejection in organ transplantation and acute graft-versus-host disease. Studies suggest that it may be of benefit in psoriasis, pemphigus vulgaris, bullous pemphigoid, Behçet's ...
E H, Page, D M, Wexler, L C, Guenther
  +6 more sources

Neoral: a microemulsion cyclosporine

Journal of Transplant Coordination, 1996
Cyclosporine (Sandimmune), introduced in the 1980s, improved patient and graft survival rates primarily by decreasing the frequency and severity of early, acute rejection. Today, the challenge for coordinators and clinicians is to promote long-term clinical stability in transplant recipients.
openaire   +2 more sources

Cyclosporin A

Reactions, 1982
  +11 more sources

Cyclosporin A

Nature, 1995
David D. Ho, Alan S. Perelson, George M. Shaw   +2 more
  +4 more sources

Cyclosporin A

Report on carcinogens : carcinogen profiles, 2011
  +8 more sources

Cyclosporin A

2016
In 1976, Jean-Francois Borel et al. [1] described the possible use of cyclosporin A (CsA) for the treatment of autoimmune disease. Since then, CsA has been studied in virtually every known autoimmune disease in man, ranging from systemic lupus erythematosus (SLE), psoriasis and inflammatory bowel disease to rheumatoid arthritis and to diseases like ...
Baarsma, Goitze Seerp, Caspers, Laure
openaire   +1 more source

Cyclosporin A

Annales de l'Institut Pasteur / Immunologie, 1987
Gernot Rassner, Ursula Steinert
openaire   +3 more sources

CYCLOSPORIN A

The Lancet, 1979
openaire   +3 more sources